JSM 2011 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Activity Details

89 Sun, 7/31/2011, 4:00 PM - 5:50 PM CC-D231/232
Analysis of Survival Data — Contributed Papers
Biopharmaceutical Section
Chair(s): Mulugeta Gebregziabher, Medical University of Medical University of South Carolina
4:05 PM Two-Component Mixture Cure Rate Model with Spline-Estimated Nonparametric Components Lu Wang, Novartis Oncology
4:20 PM Stratified Time-to-Event Trials: Is There a Best Analysis? Devan V. Mehrotra, Merck Research Laboratories ; Shu-Chih Su, Merck & Co., Inc. ; Xiaoming Li, Merck Research Laboratories
4:35 PM Sample Size Calculation for Proportional Hazards Cure Model Songfeng Wang, University of South Carolina ; Jiajia Zhang, University of South Carolina ; Wenbin Lu, North Carolina State University
4:50 PM Analysis of a Composite Endpoint Under Different Censoring Schemes for Component Events Chunlei Ke, Amgen Inc. ; Beiying Ding, Amgen Inc. ; Jianming Wang, Novartis Oncology ; Qi Jiang, Amgen Inc.
5:05 PM Assessing Evaluation-Time Bias in Progression-Free Survival Data Analysis — Chen Hu, University of Michigan ; Kalyanee Viraswami-Appanna, Novartis ; Bharani Bharani-Dharan, Novartis
5:20 PM Floor Discussion

2011 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.